ArticleBMC public health2025
Appraisal of community-based interventions for hepatitis B in underserved populations using the quadruple aim of value-based medicine: a scoping review within the VH-COMSAVAC project.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hepatitis B virus prevalence, susceptibility and care engagement among vulnerable migrant populations in Rome.BMC infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic viral hepatitis remains a critical public health concern, a key focus of WHO's 2030 elimination targets. High-risk populations, especially migrants often facing significant healthcare barriers, are disproportionately affected globally by this condition. Community-based interventions are crucial for enhancing access to screening, vaccination, and linkage to care. This scoping review, a foundational step within the EU co-funded VH-COMSAVAC project, identifies and analyses how these interventions map to the Quadruple Aim framework of value-based medicine.
methodsThis scoping review adhered to PRISMA-ScR guidelines. Five scientific databases (MEDLINE, Embase, GlobalHealth, Scopus, Web of Science) were systematically searched up to July 30, 2023. Titles and abstracts of studies focusing on community-based HBV interventions, primarily targeting migrants and refugees while also encompassing other underserved populations, were independently screened by five reviewers using the Rayyan platform. Data extraction was conducted using a structured Excel spreadsheet, mapping reported outcomes to the Quadruple Aim framework (patient experience, population health, cost reduction, care team wellbeing) and intervention types (prevention, linkage to care, treatment).
resultsOf 34 included publications, 94% (n = 32) focused on prevention, 29% (n = 10) on linkage to care, and 6% (n = 2) on treatment strategies. Patient experience was the most reported value domain (56%, n = 19 studies), followed by population health (50%, n = 17 studies). Cost reduction (9%, n = 3 studies) and care team wellbeing (3%, n = 1 study) were considerably less represented. Point-of-care (PoC) testing demonstrated significantly higher linkage to care (86% vs. 34% for venepuncture) and 76.5% lower costs (€12.7 vs. €54.0 per screened person). Screening uptake in targeted intervention groups (19.5%) was also significantly higher than in control groups (1.7%; p = 0.014). Major reported barriers included language (62%), cultural/religious issues (50%), and lack of knowledge (32%).
conclusionsThe review reveals a significant gap in the comprehensive, value-based evaluation of existing community-based interventions, with no established framework existing. The VH-COMSAVAC project seeks to bridge this by developing a value-based assessment tool, leveraging the Quadruple Aim, to systematically assess its prevention and linkage-to-care interventions and guide evidence-based optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.